JPMorgan Lifts Humana Stock Price Target to $393.00

Humana's stock price has been boosted by analysts at JPMorgan Chase & Co., who have increased their target price from $316.00 to $393.00 in a recent report.

This represents a potential upside of 1.74% from the stock's previous close.

The firm currently maintains a 'neutral' rating on Humana's stock, indicating that the analysts do not have a strong buy or sell recommendation.

Other firms such as UBS Group, Guggenheim, and Truist Financial have also raised their price targets for Humana in recent months, with some predicting significant growth potential for the company.